Alder BioPharmaceuticals Inc. (ALDR) Declined -5.31% or -0.85 To Price $15.15 On Wednesday


Alder BioPharmaceuticals Inc. (ALDR) declined -5.31% or -0.85 to $15.15. It is close to 840241 shares traded, which is 69.09% compare to the average total volume 1.22 million. The market cap of ALDR is $1.03 billion. The year to date change is 23.72%. The 52 week price range is from $8.6 to $19.35. Price of ALDR have changed -11.11% during last week. It have changed 1.59% over last month, 33.89% over last 3 months, 38.53% over last 6 months and -14.44% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ALDR is 15.58. It is 2.84% above current price. The 200-day Moving Averages for ALDR is 13.36. It is -11.82% below current price. The 52-week High is 19.35. It is 27.72% from the current price. The 52-week Low is 8.6. It is -43.23% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ALDR is 11.39 on 2018-05-31. Short % to float is 16.96%. There are some statistics of ALDR. It is has market cap $1.03 billion. The share outstanding is 67.85 million. The average volume is 1.22 million. The revenue is 683000. The percent of top 15 Institution holding is 95.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ALDR is -103.74%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ALDR is -66.75%.


Tags:

Share this post